Definitive Healthcare (DH) Set to Announce Quarterly Earnings on Tuesday

Definitive Healthcare (NASDAQ:DHGet Free Report) is scheduled to be issuing its quarterly earnings data after the market closes on Tuesday, May 7th. Analysts expect the company to announce earnings of $0.08 per share for the quarter. Parties interested in participating in the company’s conference call can do so using this link.

Definitive Healthcare (NASDAQ:DHGet Free Report) last posted its earnings results on Wednesday, February 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.01 by ($0.02). The company had revenue of $65.93 million for the quarter, compared to the consensus estimate of $66.01 million. Definitive Healthcare had a negative net margin of 80.40% and a positive return on equity of 0.43%. On average, analysts expect Definitive Healthcare to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Definitive Healthcare Price Performance

DH opened at $7.03 on Friday. The company has a debt-to-equity ratio of 0.20, a quick ratio of 2.31 and a current ratio of 2.31. The stock has a market capitalization of $828.06 million, a P/E ratio of -3.95, a P/E/G ratio of 6.09 and a beta of 1.41. The company’s 50-day simple moving average is $7.85 and its two-hundred day simple moving average is $8.30. Definitive Healthcare has a 52-week low of $5.53 and a 52-week high of $12.45.

Analysts Set New Price Targets

Several research firms have issued reports on DH. Barclays upped their target price on shares of Definitive Healthcare from $10.00 to $11.00 and gave the company an “equal weight” rating in a research note on Friday, March 1st. Needham & Company LLC cut shares of Definitive Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday, January 17th. Stifel Nicolaus lowered their target price on shares of Definitive Healthcare from $12.00 to $11.00 and set a “buy” rating on the stock in a research note on Wednesday, January 17th. Finally, Canaccord Genuity Group increased their price objective on shares of Definitive Healthcare from $9.00 to $10.00 and gave the stock a “hold” rating in a research note on Thursday, February 29th. Seven analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $11.31.

Check Out Our Latest Stock Report on DH

About Definitive Healthcare

(Get Free Report)

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.

Featured Stories

Earnings History for Definitive Healthcare (NASDAQ:DH)

Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.